HeadlinesReuters Ant Group Founder Jack Ma To Give Up Control In Key Restructuring The Cheap InvestorJanuary 6, 20230 By Yingzhi Yang and Brenda Goh SHANGHAI (Reuters) -Ant Group said on Saturday its founder Jack Ma will no longer…
HeadlinesReuters Eisai Files For Full FDA Approval For Alzheimer’s Drug Leqembi The Cheap InvestorJanuary 6, 20230 (Reuters) – Japanese drugmaker Eisai Co Ltd said on Saturday it had submitted an application to the U.S. Food and…
HeadlinesReuters Jack Ma To Relinquish Control Of Ant Group The Cheap InvestorJanuary 6, 20230 SHANGHAI (Reuters) -Ant Group’s founder Jack Ma will no longer control the Chinese fintech giant after the firm’s shareholders agreed…
HeadlinesReuters Ant Group Says Jack Ma Relinquishes Control Of Company The Cheap InvestorJanuary 6, 20230 SHANGHAI (Reuters) – China’s Ant Group said on Saturday that its founder Jack Ma no longer controls the Chinese fintech…
HeadlinesReuters Explainer-Why The U.S.-Mexico Energy Spat Is A Tough Nut To Crack The Cheap InvestorJanuary 6, 20230 By Isabel Woodford MEXICO CITY (Reuters) – The leaders of the United States, Canada and Mexico are due to hold…
HeadlinesReuters Salesforce Aims To Cut Costs By $3 Billion To $5 Billion – Fortune The Cheap InvestorJanuary 6, 20230 (Reuters) – Salesforce Inc is looking to cut costs by $3 billion to $5 billion, Chief Executive Marc Benioff told…
HeadlinesReuters Mexican Govt Inks Deal To Buy Mexicana Airline Brand For $42 Million, Union Says The Cheap InvestorJanuary 6, 20230 By Kylie Madry MEXICO CITY (Reuters) -The Mexican government signed a deal with several aviation unions Friday to purchase the…
HeadlinesReuters U.S. Job Growth Solid In December; Wage Growth Slows The Cheap InvestorJanuary 6, 20230 By Lucia Mutikani WASHINGTON (Reuters) – The U.S. economy added jobs at a solid clip in December, pushing the unemployment…
HeadlinesReuters McDonald’s To Boost Restaurant Growth, Streamline Some Programs The Cheap InvestorJanuary 6, 20230 By Hilary Russ NEW YORK (Reuters) -Burger chain McDonald’s Corp said on Friday that it will review corporate staffing levels…
HeadlinesReuters U.S. FDA Approves Eisai, Biogen Alzheimer’s Drug The Cheap InvestorJanuary 6, 20230 By Deena Beasley (Reuters) -The U.S. Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai…